Clinical trial
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and…
NCT04330495 · Instituto de Investigación Marqués de Valdecilla, Other · Withdrawn
Key facts
| NCT number | NCT04330495 |
|---|---|
| Title | Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection |
| Official title | Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection |
| Lead sponsor | Instituto de Investigación Marqués de Valdecilla, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | COVID 19, Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors |
| Intervention type | Drug |
| Interventions | Hidroxicloroquina, Control group |
| Enrollment | 0 |
| Start date | Apr 6, 2020 |
| Primary completion | Nov 6, 2020 |
| Completion | Aug 27, 2021 |
| First posted | Apr 1, 2020 |
| Last update posted | Sep 16, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: